Session » ARHP Rheumatoid Arthritis - Clinical Aspects: Clinical Practice/Patient Care

Meeting: 2013 ACR/ARHP Annual Meeting

Abstract Number: 2306

Comparative Study Of Patients With Peripheral Psoriatic Arthritis, Axial Psoriatic Arthritis and Axial Spondyloarthritis Without Psoriasis

Abstract Number: 2307

Lifestyle Factors Were Seldom Discussed With Patients Visiting a Rheumatology Clinic

Abstract Number: 2308

Rheumatoid Arthritis Flares: Inflammatory Or Avalanche?

Abstract Number: 2309

Quantifying The Gap Between General Population Guidelines and Expert Opinion For Cardiovascular Risk Management In Rheumatic Disease Patients

Abstract Number: 2310

Nurse Training; Confidence and Competence For Educating Patients Commencing Methotrexate Therapy

Abstract Number: 2311

Impact Of Healing Architecture In a Rheumatology Outpatient Clinic

Abstract Number: 2312

Experiences Of Older People Living With Ankylosing Spondylitis

Abstract Number: 2313

Pain-Related Anxiety As a Barrier To Use Of Methotrexate In Rheumatoid Arthritis: Comparing Conventional Vial, Needles, and Syringe With An Investigational Auto-Injector In Healthy Volunteers

Abstract Number: 2315

Reducing The Need For Total Knee Arthroplasty: The Experience Of a Multidisciplinary Osteoarthritis Clinic

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.